A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.

@article{Xia2014ARA,
  title={A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.},
  author={Jingjing Xia and Duchao Zhang and Yaping Xu and Meiliang Gong and Yu Zhou and Xiangqun Fang},
  journal={International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases},
  year={2014},
  volume={23},
  pages={90-3}
}
BACKGROUND Acinetobacter baumannii has been reported increasingly as a significant causative organism of various nosocomial infections, including hospital-acquired pneumonia (HAP). The aim of this study was to investigate the clinical characteristics of HAP induced by carbapenem-resistant A. baumannii (CRAB) in elderly patients and the in vitro antimicrobial effects of cefoperazone/sulbactam combination therapy. METHODS Seventy-one elderly patients in the geriatric ward of the General… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 32 references

CHINET 2010 surveillance of bacterial resistance in China

DM Zhu, F Wang, +3 authors JY Sun
Chin J Infect Chemother • 2011
View 1 Excerpt

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne • 2011

Risk factors for hospital-acquired pneumonia in nonventilated adults.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases • 2009

Similar Papers

Loading similar papers…